Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qufu Guanglong Biochem is a China-based manufacturer of hyaluronic acid, chondroitin sulfate, gelatin, collagen, glucosamine, and related biochemical and pharmaceutical ingredient products. The company appears to operate primarily as a commercial supplier rather than a drug developer, with products spanning raw materials, injectable-grade sodium hyaluronate, cross-linked hyaluronic acid dermal fillers, cosmetics, health foods, and OEM/ODM services. Publicly available trade-directory profiles describe GMP-compliant workshops and fermentation, purification, and testing capabilities supporting industrial-scale production. Its business is focused on manufacturing and export of health- and medicine-related ingredients and finished products, especially hyaluronic-acid-based aesthetic and wellness products. There is no clear evidence of a proprietary therapeutic pipeline or clinical-stage drug development program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qufu Guanglong Biochem.